Cargando…

Pharmacist-Led Programs to Increase Statin Prescribing: A Narrative Review of the Literature

Statins are lipid-lowing medications shown to reduce cardiovascular events and are recommended for specific patient populations at elevated risk of atherosclerotic cardiovascular disease (ASCVD). Despite the demonstrated efficacy of statins for reducing ASCVD risk, and guidance on which populations...

Descripción completa

Detalles Bibliográficos
Autores principales: Elkomos, Mary, Jahromi, Raha, Kelly, Michael S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788429/
https://www.ncbi.nlm.nih.gov/pubmed/35076632
http://dx.doi.org/10.3390/pharmacy10010013
_version_ 1784639562223452160
author Elkomos, Mary
Jahromi, Raha
Kelly, Michael S.
author_facet Elkomos, Mary
Jahromi, Raha
Kelly, Michael S.
author_sort Elkomos, Mary
collection PubMed
description Statins are lipid-lowing medications shown to reduce cardiovascular events and are recommended for specific patient populations at elevated risk of atherosclerotic cardiovascular disease (ASCVD). Despite the demonstrated efficacy of statins for reducing ASCVD risk, and guidance on which populations should receive statin therapy, a substantial portion of eligible patients are not prescribed statin therapy. Pharmacists have attempted to increase the number of eligible patients receiving appropriate statin therapy through a variety of interventions and across several clinical settings. In this article, we highlight multiple studies evaluating the effectiveness of pharmacist-led interventions to improve statin use. A total of seven studies were selected for this narrative review, demonstrating the effectiveness and barriers of different statin-initiation programs delivered by pharmacists to increase statin use in eligible patients. Among the interventions assessed, a combination of provider communicating and statin prescribing through collaborative drug therapy management (CDTM) appear to the be the most useful at increasing statin use. Pharmacists can significantly improve statin use rates among eligible patients through multiple intervention types and across different clinical settings. Further studies should evaluate continued statin adherence and clinical outcomes among patients served by pharmacists.
format Online
Article
Text
id pubmed-8788429
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87884292022-01-26 Pharmacist-Led Programs to Increase Statin Prescribing: A Narrative Review of the Literature Elkomos, Mary Jahromi, Raha Kelly, Michael S. Pharmacy (Basel) Review Statins are lipid-lowing medications shown to reduce cardiovascular events and are recommended for specific patient populations at elevated risk of atherosclerotic cardiovascular disease (ASCVD). Despite the demonstrated efficacy of statins for reducing ASCVD risk, and guidance on which populations should receive statin therapy, a substantial portion of eligible patients are not prescribed statin therapy. Pharmacists have attempted to increase the number of eligible patients receiving appropriate statin therapy through a variety of interventions and across several clinical settings. In this article, we highlight multiple studies evaluating the effectiveness of pharmacist-led interventions to improve statin use. A total of seven studies were selected for this narrative review, demonstrating the effectiveness and barriers of different statin-initiation programs delivered by pharmacists to increase statin use in eligible patients. Among the interventions assessed, a combination of provider communicating and statin prescribing through collaborative drug therapy management (CDTM) appear to the be the most useful at increasing statin use. Pharmacists can significantly improve statin use rates among eligible patients through multiple intervention types and across different clinical settings. Further studies should evaluate continued statin adherence and clinical outcomes among patients served by pharmacists. MDPI 2022-01-07 /pmc/articles/PMC8788429/ /pubmed/35076632 http://dx.doi.org/10.3390/pharmacy10010013 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Elkomos, Mary
Jahromi, Raha
Kelly, Michael S.
Pharmacist-Led Programs to Increase Statin Prescribing: A Narrative Review of the Literature
title Pharmacist-Led Programs to Increase Statin Prescribing: A Narrative Review of the Literature
title_full Pharmacist-Led Programs to Increase Statin Prescribing: A Narrative Review of the Literature
title_fullStr Pharmacist-Led Programs to Increase Statin Prescribing: A Narrative Review of the Literature
title_full_unstemmed Pharmacist-Led Programs to Increase Statin Prescribing: A Narrative Review of the Literature
title_short Pharmacist-Led Programs to Increase Statin Prescribing: A Narrative Review of the Literature
title_sort pharmacist-led programs to increase statin prescribing: a narrative review of the literature
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788429/
https://www.ncbi.nlm.nih.gov/pubmed/35076632
http://dx.doi.org/10.3390/pharmacy10010013
work_keys_str_mv AT elkomosmary pharmacistledprogramstoincreasestatinprescribinganarrativereviewoftheliterature
AT jahromiraha pharmacistledprogramstoincreasestatinprescribinganarrativereviewoftheliterature
AT kellymichaels pharmacistledprogramstoincreasestatinprescribinganarrativereviewoftheliterature